<?xml version="1.0" encoding="UTF-8"?>
<p id="Par41">Similar inhibition was observed for MERS-CoV when 10 μg/ml of Echinaforce® reduced infectivity by 99.9% and 50 μg/ml of Echinaforce fully blocked infectivity (Engler et al. 
 <xref ref-type="bibr" rid="CR31">2017</xref>). Extracts of 
 <italic>Echinacea purpurea</italic> have been used traditionally in North America for the treatment of various infections and wounds, and they have become very popular herbal medicines globally (Hudson 
 <xref ref-type="bibr" rid="CR44">2012</xref>). Rondanelli et al. (
 <xref ref-type="bibr" rid="CR97">2018</xref>) found that a combination of 
 <italic>E. purpurea</italic>, vitamin D, vitamin C, and zinc was useful in the treatment of the common cold. Vitamin D supplementation also lessens the risk of COVID-19 infection and deaths (Grant et al. 
 <xref ref-type="bibr" rid="CR36">2020</xref>). 
 <italic>Echinacea angustifolia</italic> DC., 
 <italic>Echinacea pallida</italic> (Nutt.) Nutt., and 
 <italic>Echinacea purpurea</italic> are the most common 
 <italic>Echinacea</italic> Moench species recognized for treating common cold and SARS (Hudson 
 <xref ref-type="bibr" rid="CR44">2012</xref>).
</p>
